Pharmaceutically acceptable salts, crystalline forms, and uses of diaminocyclopentyl-substituted heteroaryl derivatives
TW202635678APending Publication Date: 2026-09-01JIANGSU HENGRUI MEDICINE CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115102672
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-23
- Filing Date
- 2026-01-22
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001075194_001 
Figure TWG2TA001075194_002 
Figure TWG2TA001075194_003
Abstract
The present disclosure relates to pharmaceutically acceptable salts, crystalline forms, and uses of diaminocyclopentyl-substituted heteroaryl derivatives. Specifically, the present disclosure provides pharmaceutically acceptable salts, crystal forms, and preparation methods of 1-(6-{[(1S,3S)-3-(6,7-dihydro[1,4]dioxepino[3,2-d]pyrimidin-2-ylamino)cyclopentyl]amino}pyridin-3-yl)-1,2-dihydropyridin-2-one, which exhibit excellent stability and are suitable for clinical applications.
Need to check novelty before this filing date? Find Prior Art